
Sam Altman’s New Venture, Merge Labs, Targets Non‑Invasive Brain‑Computer Interfaces
Sam Altman is preparing to launch a brain‑computer interface startup, Merge Labs, alongside co‑founder Alex Blania. The company has recruited Caltech biomolecular engineer Mikhail Shapiro to its founding team and is expected to seek hundreds of millions of dollars in funding from OpenAI and other investors. Merge Labs aims to develop non‑invasive neural technologies that use ultrasound and gene‑editing techniques, positioning itself as a contrast to more invasive approaches such as Neuralink. Altman has publicly expressed a preference for read‑only, non‑surgical interfaces that could let users interact with AI systems like ChatGPT directly with thought.









